European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus vaccine (inactivated, recombinant) - immunologicals for suidae, inactivated viral vaccines - pigs (for fattening) - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.,

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - porcine parvo virus - inactivated; thiomersal - misc. vaccines or anti sera - porcine parvo virus - inactivated vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - parvovirus

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines inc.; distributor: zoetis philippines inc. - porcine circovirus (pcv) inactivated chimera vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: inactivated porcine circovirus (pcv) (type 1-2 chimera)........... ≥ 1.3 rp (type 1-2b chimera)...............≥ 1.3 rp rp-relative potency

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.

European Union - English - EMA (European Medicines Agency)

ceva-phylaxia oltóanyagtermelõ zrt. - inactivated porcine circovirus type 2 (pcv2) - immunologicals for suidae - pigs (gilts and sows) - sows and giltspassive immunisation of piglets via the colostrum, after active immunisation of sows and gilts, to reduce lesions in lymphoid tissues associated with pcv2 infection and as an aid to reduce pcv2-linked mortality.pigletsactive immunisation of piglets to reduce faecal excretion of pcv2 and virus load in blood, and as an aid to reduce pcv2-linked clinical signs, including wasting, weight loss and mortality, as well as to reduce virus load and lesions in lymphoid tissues associated with pcv2 infection.

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines inc.; distributor: zoetis philippines inc. - porcine circovirus (pcv) chimera vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: inactivated porcine circovirus (pcv) (type 1-2 chimera)............... 21.3 rp rp-relative potency

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein; carbomer - misc. vaccines or anti sera - porcine circovirus type 2 orf2 protein vaccine-viral active 1.0 ml/do; carbomer ungrouped other 1.0 mg - immunotherapy - pigs - see label for type - disease control

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus recombinant virus (cpcv) 1-2, inactivated - immunologicals - pigs (piglets) - active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with pcv2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - misc. vaccines or anti sera - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 2.0 mg/2ml - immunotherapy

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.